SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-077543
Filing Date
2022-07-06
Accepted
2022-07-06 07:00:33
Documents
12
Period of Report
2022-07-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220477d1_8k.htm   iXBRL 8-K 24507
  Complete submission text file 0001104659-22-077543.txt   197356

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btai-20220706.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20220706_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20220706_pre.xml EX-101.PRE 22617
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2220477d1_8k_htm.xml XML 3617
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 221067378
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences